Synaptive launches next-gen robotic exoscope
23 Mar 2023
Toronto-based Synaptive Medical designed Modus X with 4K 3D optics, 27-times magnification, automated image focus, voice guidance and more. The platform enables fluorescence-guided surgery to improve oncological tissue differentiation in real time.
Additionally, Modus X’s flexible design allows for field upgrades of Modus V, the previous-generation exoscope. Synaptive said in a news release that 80 hospitals worldwide have the Modus V system installed.
Modus X joins the Synaptive integrated suite of products connecting clinicians in operating rooms. It spans mid-field MRI, surgical planning and navigation, plus surgical visualization. The company says it designed its services to automate critical patient data through every step of surgical intervention. This improves clinical decision-making.
“We anticipate these enhanced visualization capabilities will enable surgeons to perform even more effective and precise interventions to the benefit of their patients,” said Cameron Piron, president and co-founder of Synaptive Medical. “Through years of interdisciplinary collaboration with our clinical partners, we have arrived at this ultimate platform that pushes the boundaries of surgical visualization.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.